Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
User Sign In Health checkup offers
FISH for c-MYC, Solid Tumor

FISH for c-MYC, Solid Tumor

Fluorescence in situ hybridization, or FISH, is a sophisticated laboratory technique employed to detect and locate specific DNA sequences on chromosomes. When it comes to cancer diagnostics and research, the FISH technique is particularly invaluable. One such application is in the analysis of the c-MYC gene in solid tumors. The c-MYC gene is a critical regulator of cell growth and proliferation. Abnormalities in this gene, such as amplification or translocation, are associated with several types of cancer.

The FISH for c-MYC in solid tumors allows for the visualization of the c-MYC gene by employing fluorescent probes that bind to it. The test is chiefly employed to detect changes in the gene that could signify the presence or progression of cancer. In the domain of oncology, having precise genetic information at hand is paramount to establishing an effective treatment strategy.

  • Test NameFISH for c-MYC, Solid Tumor
  • Sample TypeParaffin embedded tissue blocks
  • Preparations RequiredThere are no specific preparations required for this test.
  • Report Time7 days

What is the importance of the FISH test for c-MYC in solid tumors?

The FISH test for c-MYC is essential for diagnosing and monitoring different types of cancer. Abnormalities in the c-MYC gene are often associated with aggressive tumor behavior, and the detection of such changes can be crucial for the management and treatment of cancer.

Is fasting required for this test?

No, fasting is not required for the FISH test for c-MYC in solid tumors.

Home Sample Collection Process

Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

This test is usually recommended by a doctor for patients who have been diagnosed with a solid tumor. It can also be used for monitoring purposes or to determine the aggressiveness of the tumor.

The test provides information on the genetic alterations in the c-MYC gene. It helps in determining whether the gene is amplified or if there's a translocation, which can have implications in the tumor’s aggressiveness and responsiveness to therapy.

The frequency of the test depends on the doctor’s recommendation and the patient's health status. It is generally performed at the time of diagnosis and might be repeated for monitoring purposes.

Normal results would indicate no significant alterations in the c-MYC gene. However, it’s best to discuss the specific results with a doctor who can interpret them in the context of the patient’s overall health and medical history.

No special precautions are needed for this test. However, patients should inform their doctor about any medications or supplements they are taking, as these could potentially affect the test results.

Genetic factors, exposure to certain chemicals, and underlying health conditions can affect the levels of c-MYC in solid tumors.

If your test results are abnormal, it's important to discuss the findings with your doctor, who can provide guidance on the appropriate next steps and treatment options.

If the test values are abnormal, consulting an oncologist is advisable.

Yes, alterations in the c-MYC gene can have implications on how a tumor responds to certain treatments. The information from the test can therefore guide personalized treatment plans.

There are minimal risks associated with this test as it generally involves the analysis of tissue that has already been biopsied for other diagnostic purposes.

Yes, there are therapies that target the c-MYC gene and its pathways, although developing effective therapies is challenging because of the gene’s complex nature.

Gene amplification involves the increase in the number of copies of a specific gene, while translocation involves the rearrangement of parts between nonhomologous chromosomes.

No, c-MYC abnormalities can also be associated with hematological malignancies like Burkitt's lymphoma.

The FISH technique to study the c-MYC gene in solid tumors is a potent tool in modern oncology. Not only does it aid in the diagnosis of cancer, but it can also provide insights into the nature of the tumor, which can be pivotal in forming a treatment plan. This test is yet another example of how advances in genetics are increasingly playing a role in the fight against cancer. If you or a loved one are faced with a diagnosis of a solid tumor, it’s prudent to discuss the role that c-MYC gene analysis might play in your care with your doctor.

FISH for c MYC, Solid Tumor
₹ 8900
Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet